Biogen Inc (BIIB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 3,593,200 | 2,941,600 | 1,862,300 | 1,380,033 | 1,266,686 |
| Depreciation Amortization | 600,400 | 688,100 | 531,700 | 365,648 | 358,933 |
| Income taxes - deferred | -145,600 | -308,200 | -245,100 | -116,900 | 153,576 |
| Accounts receivable | 29,000 | -512,400 | -126,700 | 3,571 | -73,374 |
| Other Working Capital | -450,400 | -484,400 | 87,500 | 103,728 | -184,612 |
| Other Operating Activity | 292,800 | 617,400 | 235,400 | 143,817 | 206,532 |
| Operating Cash Flow | $3,919,400 | $2,942,100 | $2,345,100 | $1,879,897 | $1,727,741 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -643,000 | -287,800 | -246,300 | -254,548 | -208,020 |
| Net Acquisitions | -1,048,800 | -375,000 | -15,000 | -72,401 | -5,000 |
| Purchase Of Investment | -6,864,900 | -3,583,100 | -3,278,100 | -3,334,434 | -3,696,995 |
| Sale Of Investment | 4,063,000 | 2,718,900 | 5,190,100 | 2,749,558 | 2,276,720 |
| Purchase Sale Intangibles | -15,400 | -28,200 | -3,262,700 | 0 | N/A |
| Other Investing Activity | -59,900 | -16,000 | -3,255,400 | -38,517 | -16,999 |
| Investing Cash Flow | $-4,553,600 | $-1,543,000 | $-1,604,700 | $-950,342 | $-1,650,294 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,930,500 | 0 | 0 | N/A | N/A |
| Debt Repayment | -2,100 | -2,700 | -452,400 | -2,428 | -11,459 |
| Common Stock Issued | -70,900 | 54,900 | 66,800 | 67,493 | 314,650 |
| Common Stock Repurchased | -5,000,000 | -886,800 | -400,300 | -984,715 | -497,975 |
| Other Financing Activity | -74,400 | 78,700 | 69,400 | 42,172 | -125,078 |
| Financing Cash Flow | $783,100 | $-755,900 | $-716,500 | $-877,478 | $-319,862 |
| Exchange Rate Effect | -45,800 | -40,900 | 8,000 | 4,102 | -2,641 |
| Beginning Cash Position | 1,204,900 | 602,600 | 570,700 | 514,542 | 759,598 |
| End Cash Position | 1,308,000 | 1,204,900 | 602,600 | 570,721 | 514,542 |
| Net Cash Flow | $103,100 | $602,300 | $31,900 | $56,179 | $-245,056 |
| Free Cash Flow | |||||
| Operating Cash Flow | 3,919,400 | 2,942,100 | 2,345,100 | 1,879,897 | 1,727,741 |
| Capital Expenditure | -643,000 | -287,800 | -246,300 | -254,548 | -208,020 |
| Free Cash Flow | 3,276,400 | 2,654,300 | 2,098,800 | 1,625,349 | 1,519,721 |